• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct31
Plus Therapeutics released FY2025 9 Months Earnings on October 30, 2025 (EST) with actual revenue of USD 3.846 M and EPS of USD -29.5631
03:00
Plus Therapeutics released FY2025 Q3 earnings on October 30 (EST), actual revenue USD 1.397 M (forecast USD 1.5 M), actual EPS USD -0.0411 (forecast USD -0.0275)
03:00
Sep25
UnitedHealth Insurance Reaches National Coverage Agreement with Plus Therapeutics for CNSide CSF Test
12:22
Aug15
Plus Therapeutics Meets NASDAQ Listing Rules and Receives Compliance Extension
13:49
Plus Therapeutics released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 2.449 M, actual EPS USD -0.5015
03:00
Plus Therapeutics released FY2025 Q2 earnings on August 14 (EST), actual revenue USD 1.39 M (forecast USD 1.486 M), actual EPS USD -0.01 (forecast USD -0.09)
03:00

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.397 M, Net Income -4.423 M, EPS -0.0411

Aug14
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 1.39 M, Net Income 1.191 M, EPS -0.0065

May30
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 1.059 M, Net Income -13.44 M, EPS -29.5154

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More